dr. william gradishar on updates in nccn breast cancer guidelines
Published 8 years ago • 587 plays • Length 2:09Download video MP4
Download video MP3
Similar videos
-
1:38
dr. william gradishar discusses the eribulin and capecitabine 301 study
-
2:57
dr. gradishar comments on the treatment of early stage breast cancer with endocrine therapy
-
0:50
dr. gradishar discusses dual her2-targeting in breast cancer
-
1:22
dr. william gradishar discusses 10 years of adjuvant tamoxifen
-
8:08
pancreatic cancer: updated nccn guidelines
-
3:01
her2 biosimilars in clinical practice - an interview with dr. william gradishar.mp4
-
1:02
dr. gradishar discusses the results of the bolero-1 trial
-
0:57
dr. william gradishar reviews findings from the phase iii lea trial
-
5:15
mechanisms and implications of her2 resistance - an interview with dr. william gradishar
-
4:03
nccn guideline changes for brca testing in tnbc
-
1:59
william j. gradishar, md
-
7:44
hormonal and her2-targeted therapy in early breast cancer
-
1:52
dr. salerno discusses hypofractionation for early breast cancer
-
1:12
dr. atreya on how the nccn guidelines have impacted treatment options in mcrc
-
27:26
would you choose oncology again? and breast cancer research review with dr. bill gradishar:...
-
6:55
extended adjuvant therapy for her2 early breast cancer
-
1:57:47
drs. hamilton, gradishar, rugo, & schmid discuss #breastcancer at #sabcs22 - http://bit.ly/3zedpm8
-
2:51
scripps otolaryngologist brendan gaylis, md
-
0:18
copy of dr. goetz on treatment of metastatic hr breast cancer